P. Olmos et al., Aldose reductase gene polymorphism and rate of appearance of retinopathy in non insulin dependent diabetics, REV MED CHI, 127(4), 1999, pp. 399-409
Background: Recent studies suggest that polymorphisms associated to the ald
ose reductase gene could be related to early retinopathy in noninsulin depe
ndent diabetics (NIDDM). There is also new interest on the genetic modulati
on of coagulation factors in relation to this complication. Aim: To look fo
r a possible relationship between the rate of appearance of retinopathy and
the genotype of (AC)(n) polymorphic marker associated to aldose reductase
gene. Patients and methods: A random sample of 27 NIDDM, aged 68.2 +/- 10.6
years, with a mean diabetes duration of 20.7 +/- 4.8 years and a mean glyc
osilated hemoglobin of 10.6 +/- 1.6%, was studied. The genotype of the (AC)
(n) polymorphic marker associated to the 5' end of the aldose reductase (AL
R2) gene was determined by 32P-PCR plus sequenciation. Mutations of the fac
tor XIII-A gene were studied by single stranded conformational polymorphism
, sequenciation and restriction fragment length polymorphism. Results: Four
patients lacked the (AC)(24) and had a higher rate of appearance of retino
pathy than patients with the (AC)(24) allele (0.0167 and 0.0907 score point
s per year respectively, p=0.047). Both groups had similar glycosilated hem
oglobin (11.7 +/- 0.2 and 10.5 +/- 1.6% respectively). Factor XIII gene mut
ations were not related to the rate of appearance appearance of retinopathy
. Conclusions: Our data suggest that the absence of the (AC)(24) allele of
the (AC)(n) polymorphic marker associated to the 5' end of the aldose reduc
tase gene, is associated to a five fold reduction of retinopathy appearance
rate.